USPTO serial 79405073
EPIFINDER
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Oct 28, 2025
- Examiner
- MAHONEY, PAULA M
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with EPIFINDER?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Joseph R. Dages
Joseph R. Dages Gray Ice Higdon, PLLC3939 Shelbyville RoadSuite 201Louisville, KY 40207Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Genetic and epigenetic identity tests comprised of reagents for non-medical purposes; reagents for research purposes; reagents for medical research; reagents for scientific purposes; chemical diagnostic reagents for industrial purposes; reagents for chemical analyses of biological samples for scientific research and diagnostic purposes, other than for medical or veterinary purposes; chemical reagents for use in genetic and epigentic research; reagents for use in immunoserology for research purposes; diagnostic reagents for scientific use; reagents for use in environmental analysis for scientific use; biochemical reagents used for non-medical purposes; biochemical reagents, namely DNA polymerases, used for non-medical purposes; chemical diagnostic reagents for industrial use; diagnostic reagents for scientific use, other than for medical laboratory use; chemical reagents for non-medical purposes; diagnostic reagents for scientific or research use; immunoassay reagents for scientific use, other than for medical use; in-vivo diagnostic reagents for scientific use; chemical reagents for scientific use, other than for medical or veterinary purposes; reagents for scientific or medical research use; diagnostic reagents, except for medical or veterinary use; reagents for laboratory purposes, other than for medical or veterinary purposes; biomolecule labelling kits comprising reagents for use in scientific research; nucleic acid amplification reagents, other than for medical use; diagnostic reagents and preparations, except for medical or veterinary use; reagents for use in diagnostic tests, other than for medical or veterinary purposes; reagents for analytical purposes for scientific use, other than for medical or veterinary purposes; chemical reagents for molecular biology for scientific use, other than for medical or veterinary use; chemical reagents for laboratory use for scientific use, other than for medical or veterinary use; chemical reagents for use in science for scientific use, other than for medical or veterinary use; reagents for microbiological analysis for scientific use, other than for medical or veterinary purposes; chemical reagents for use with immunoassay analyzers for scientific use, other than for medical or veterinary use; diagnostic kits comprising specimen receptors and reagents for testing for selected bacteria; diagnostic reagents, other than for medical use for sale in kit form; chemical reagents for use in biotechnology for scientific use, other than for medical or veterinary use; reagents for use with analyzers for scientific use, other than for medical or veterinary purposes; chemical reagents for use in diagnostic tests for scientific purposes, other than for medical or veterinary use; reagents for use in analytical tests for scientific use, other than for medical or veterinary purposes; chemical reagents for use in diagnosis for scientific use, other than for medical or veterinary use; chemical reagents for use in analytical tests for scientific use, other than for medical or veterinary use; nucleic acids; nucleic acid reagents for use in forensic analysis, other than for medical purposes; nucleic acid sequencing programs for scientific use, other than for medical use; chromatographic material, namely, silica gel and ion-exchange resins for the treatment of nucleic acids for scientific laboratory use; monoclonal antibodies other than for medical or veterinary use, namely, for scientific purposes; tagged fluorescein- and biotin-labelled monoclonal antibodies for laboratory use; tagged fluorescein- and biotin-labelled monoclonal antibodies for scientific use; monoclonal antibodies for scientific use; monoclonal antibodies for industrial use; immunological antibodies, other than for medical use; monoclonal antibodies for diagnostic use, other than medical; proteins for use in science; proteins for binding antibodies, other than for medical use; enzymes, other than for medical use for labelling proteins; enzymes, other than for medical use for measuring proteins; proteins for detecting antibodies, other than for medical use; reagents for protein folding, namely, protein refolding buffers, other than for medical or veterinary purposes; proteins for use in recombinant dna technology for scientific use, other than for medical use; enzymes, other than for medical use for detecting protein fractions; enzymes, other than for medical use for measuring protein fractions; enzymes, other than for medical use for labelling protein fractions; enzymes for industrial purposes; enzymes for use as biochemical catalysts; enzymes for scientific use, other than for medical or veterinary use; enzymes for scientific purposes; chemicals, namely, buffer solutions used in analytical chemistry; buffer solutions for scientific purposes; buffer solutions for use in analytical chemistry; substances for use in genetic and epigenetic probe assay kits for scientific use, not for medical use; biochemical preparations for scientific purposes; biochemical precursors for scientific purposes; biochemical preparations other than for medical use; biochemical substances, namely, DNA polymerases and nucleases, other than for medical use; chemical substances for use in bioluminescent processes; biological preparations for use in industry and science; catalysts, namely, restriction enzymes and ligases, for use in non-biological processes; biological substances, namely, nucleic acid and recombinant proteins, other than for medical or veterinary use; biochemicals, namely, epigenetic assay buffers and nucleosome standards, for use as indicators, other than for medical use; reagents for use in biological processing for scientific use, other than for medical or veterinary purposes; chemicals for use in the pharmaceutical industry, namely, reagents for drug formulation and quality control assays; chemical preparations for use in the manufacture of pharmaceuticals, namely, Tris-HCl buffers, phosphate-buffered saline (PBS), and nucleic acid primers | ACTIVE | — |
| 005 | Nucleic acid sequences for medical and veterinary purposes; reagents for use in diagnostic tests for medical purposes; diagnostic preparations for medical purposes; diagnostic reagents for medical use; diagnostic preparations and materials, namely, diagnostic reagents containing primers and probes, for medical use; diagnostic reagents for medical use; diagnostic reagents for medical use in in vitro diagnosis; diagnostic substances for medical use; radio-isotope markers for therapeutic or diagnostic use; diagnostic chemical reagents for medical use; diagnostic biomarker reagents for medical purposes; diagnostic preparations for medical or veterinary purposes; diagnostic preparations for medical purposes used by medical laboratories; chemical preparations for use in DNA analysis for medical use; DNA synthesis inhibitors for medical use; chemical test reagents for medical purposes | ACTIVE | — |
| 042 | Medical and scientific research, namely, conducting clinical trials for others; design and development of diagnostic apparatus for epigenetic biomarker detection and analysis; DNA screening for scientific research purposes; DNA analysis services for scientific research purposes; research in the field of DNA repair technology; research in the field of DNA chip technology; clinical research in the field of oncology, neurology, diabetes, reproductive health, and lifestyle diseases; medical research laboratory research services; medical research; genetic and epigenetic research in plants, animals, and humans; laboratory testing of biological materials; scientific laboratory services; analytical laboratory services in the field of epigenetic biomarker detection; laboratory services for analytical testing in the field of molecular diagnostics; medical research laboratory services; laboratory research in the field of gene expression; services of a chemical and/or biological laboratory, namely, chemical laboratories, biological research laboratory services; scientific research in the field of genetics and epigenetics; genetic and epigenetic mapping for scientific purposes; DNA sequencing technology research; development of testing methods for epigenetic biomarker analysis; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; preparation of biological samples for testing and analysis in research laboratories; testing, authentication and quality control for laboratory reagents and consumables | ACTIVE | — |
| 044 | Medical services for the diagnosis of conditions of the human body; medical analysis for the diagnosis and treatment of persons; medical analysis services for the diagnosis of cancer; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; blood serum analysis of RNA or DNA, being medical analysis services for cancer diagnosis and prognosis purposes provided by medical laboratories; medical analysis services for cancer diagnosis and prognosis; DNA screening for medical purposes; medical and health services relating to DNA, genetics and epigenetics, and genetic and epigenetic testing, namely, genetic and epigenetic testing for cancer risk for medical purposes; genetic and epigenetic testing for medical purposes | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Epigenica AB
- Other trademarks owned by Epigenica AB
- Other trademarks owned by Epigenica AB
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named EPIFINDER
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| May 28, 2026 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| May 9, 2026 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| May 9, 2026 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Mar 12, 2026 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Feb 25, 2026 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Feb 25, 2026 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Jan 28, 2026 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Oct 28, 2025 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Oct 28, 2025 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Sep 9, 2025 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Sep 9, 2025 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 3, 2025 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Aug 9, 2025 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 25, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 25, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 25, 2025 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 22, 2025 | RFNT | REFUSAL PROCESSED BY IB | — |
| Feb 6, 2025 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Feb 6, 2025 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jan 1, 2025 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Dec 31, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 14, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 1, 2024 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Oct 1, 2024 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Sep 26, 2024 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |